All Articles

Editorial Commentary 
Proteomics—a new approach to identify targets and biomarkers for hepatocellular carcinoma?
Matthias Ocker
Biotarget  
2019,  
3:
6  
Letter to the Editor 
Long noncoding RNA MALAT1 and cancer metastasis
Jongchan Kim
Biotarget  
2019,  
3:
5  
Editorial Commentary 
Bronchioalveolar stem cells vindicated!
Matthew Jones, Jin-San Zhang, Saverio Bellusci
Biotarget  
2019,  
3:
4  
Editorial 
What’s up with MALAT1?
Gary A. Clawson
Biotarget  
2019,  
3:
3  
Editorial 
The new role of lncRNA MALAT1 as a tumor suppressor
Manuel Regouc, Martin Pichler
Biotarget  
2019,  
3:
2  
Editorial 
Engineered natural killer cells expressing chimeric antigen receptors (CAR)—a promising approach in tumor immunotherapy
Brigitte Neuber, Michael Schmitt
Biotarget  
2019,  
3:
1  
Editorial 
From prevention to cure, repurposing anti-viral vaccines for cancer immunotherapy
Ons Mamaï, Eswari Dodagatta-Marri, Rosemary J. Akhurst
Biotarget  
2018,  
2:
20  
Editorial 
The human papillomavirus vaccine: a potentially novel treatment for basaloid squamous cell carcinoma
Jason Levi Floyd, Ram Prasad
Biotarget  
2018,  
2:
19  
Review Article 
Effect of mammalian target of rapamycin signaling pathway on nerve regeneration
Ziwei Huang, Jianwei Zhu, Jiacheng Sun, Wenjing Ma, Lingbin Wang, Qiuyu Zhang, Hualin Sun
Biotarget  
2018,  
2:
18  
Editorial 
Simultaneous profiling of multiple genomic variations using a CRISPR-Cas9 high-throughput strategy
Pierre Cordelier
Biotarget  
2018,  
2:
17  
Editorial 
Targeting the BECN1-BCL2 autophagy regulatory complex to promote longevity
Björn Stork, Natascia Ventura
Biotarget  
2018,  
2:
16  
Editorial 
The complexity of the ubiquitination code is driven by bacteria
Francesca Nazio, Francesco Cecconi
Biotarget  
2018,  
2:
15  
Editorial 
Wnt7a and miR-370-3p: new contributors to bladder cancer invasion
Danielle Scheunemann, Anjan K. Pradhan, Swadesh K. Das, Devanand Sarkar, Luni Emdad, Paul B. Fisher
Biotarget  
2018,  
2:
14  
Editorial 
New function of Tip60 in controlling triacylglycerol synthesis
Takako Hattori
Biotarget  
2018,  
2:
13  
Editorial 
ENL YEATS domain: targeting the acute myeloid leukemia epigenome
Federica Loscocco, Giuseppe Visani, Alessandro Isidori
Biotarget  
2018,  
2:
12  
Editorial 
NKX3.2 plays a key role in regulating HIF1α-directed angiogenesis in chondrocytes
Tim J. M. Welting, Marcel Karperien, Janine N. Post
Biotarget  
2018,  
2:
11  
Editorial 
Regulation of SCF E3 ligase activity by Cand1
Maryna Gorelik, Sachdev S. Sidhu
Biotarget  
2018,  
2:
10  
Editorial 
The expanding complexity of the phosphorylation and proteolytic signaling axis of MST1
Luana C. A. Leitao, Alaa M. Ismail, Richard P. Fahlman
Biotarget  
2018,  
2:
9  
Review Article 
Strategies and potential therapeutic agents to counter skeletal muscle atrophy
Ziwei Huang, Jianwei Zhu, Wenjing Ma, Hualin Sun
Biotarget  
2018,  
2:
8  
Review Article 
The role of inflammatory factors in skeletal muscle injury
Wenjing Ma, Tongtong Xu, Ye Wang, Changyue Wu, Lingbin Wang, Xiaoming Yang, Hualin Sun
Biotarget  
2018,  
2:
7  
Review Article 
CAR-T cells shed light on the treatments of fatal liver diseases
Wen Bai, Peiwen Wang, Feng Yu
Biotarget  
2018,  
2:
6  
Editorial 
Delayed cardiomyocyte hypertrophic responses after brief exposure to endothelin-1 or phenylephrine
Maximilian Matthies, Maria Bloksgaard, Jo G. R. De Mey
Biotarget  
2018,  
2:
5  
Review Article 
Long noncoding RNAs regulate malignant phenotypes in colorectal cancer
Masahisa Ohtsuka, Masahiro Tanemura, Hiroki Akamatsu
Biotarget  
2018,  
2:
4  
Editorial 
Vertebrate RNase 1 homologs: potential regulators of extracellular RNAs
Nadezhda L. Mironova, Marina A. Zenkova
Biotarget  
2018,  
2:
3  
Editorial 
Two types of TRAF6-dependent TAK1 activation in the IL-1 signaling pathway
Giichi Takaesu
Biotarget  
2018,  
2:
2